Pilot study of FILM (5-fluorouracil, ifosfamide, leucovorin and mitomycin C): An alternative chemotherapy regimen in the treatment of advanced breast cancer

Breast

Volumn 7, Issue 2, 1998, Pages 114-118

  Davidson, N G P ^a   Cheverton, P D ^a,b   Davis, A S ^a   Campbell, N ^a  

^a NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^b ASTA Medica Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IFOSFAMIDE; MITOMYCIN C; TAMOXIFEN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BREAST CANCER; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG TOLERANCE; FATIGUE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MASTECTOMY; NAUSEA; PILOT STUDY; PRIORITY JOURNAL; VOMITING;

EID: 0031778280     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(98)90068-6     Document Type: Article

References (17)

1. Bonadonna G, Veronesi U, Brambilla C et al. Primary chemotherapy to avoid mastectomy in tumours with diameters of three centimetres or more. J Natl Cancer Inst 1990; 82: 1539-1545.
2. Bonadonna G, Valagussa P S, Zucali M D, Salvadori M D. Primary chemotherapy in surgically resectable breast cancer. Cancer J Clin 1995; 45: 226-243.
3. Smith I E, Jones A L, O'Brien M E, McKinna J A, Sacks N, Baum M. Primary medical (neo-adjuvant) chemotherapy for operable breast cancer. Eur J Cancer 1993; 29A: 1796-1799.
4. Jodrell D I, Smith I E, Mansi J L et al. A randomised comparative trial mitozatrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5-FU (CMF) in the treatment of advanced breast cancer. Br J Cancer 1991; 63: 794-798.
5. Powles T J, Jones A L, Judson I R, Hardy J R, Ashley S E. A randomised trial comparing chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) and vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer. Br J Cancer 1991; 64: 406-410.
6. Kennealy G T, Boston B, Mitchell M S et al. Combination chemotherapy for advanced breast cancer. Two regimens containing adriamycin. Cancer 1978; 42: 27-33.
7. Aisner J, Cirrincione C, Perloff M et al. Combination chemotherapy for metastatic or recurrent carcinoma of the breast: a randomised phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP. J Clin Oncol 1995 13: 1443-1452.
8. Turpin F, Serin D, Ganem G et al. Prospective randomised study of mitozantrone and vinorelbine vs fluorouracil, epirubicin or adriamycin in patients with advanced breast cancer. Eur J Cancer 1997; 33(suppl 8): s 146.
9. Andersson N, Madsen E L, Overgaard M, Dombernowsky P, Mourisden H T. CAF vs CMF both with tamoxifen in post menopausal patients with advanced breast cancer - a randomised study with more than 10 years follow-up from the Danish breast cancer cooperative group. Eur J Cancer 1997; 33(suppl 8): s 146.
10. Hortobagyi G N. Activity of ifosfamide in breast cancer. Semin Oncol 1992; 19(suppl 12): 36-42.
11. Ingle J N, Krook J E, Mailliard J A, Hartmann L C, Wieand H S. Evaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer. Am J Clin Oncol 1995; 18: 498-501.
12. De Lena M, Jirillo A, Brambilla C, Villa S. Mitomycin C in breast cancer resistant to hormone therapy and conventional chemotherapy. Tumori 1980; 66: 481-487.
13. Van Oosterom, A T, Powles T J, Hamersma E, Smith I E, Englesman. A phase II study of mitomycin C in refractory advanced breast cancer. A multi-centre study. In: Mouridsen H T, Palsof T, eds. Breast cancer - experimental and clinical aspects. Proceedings 2nd EORTC Breast Cancer Conference, Copenhagen 1979. Copenhagen: Pergamon Press, 1979: 275-276.
14. Anderson N R. 5-fluorouracil: a reappraisal of the optimal delivery in advanced breast cancer. J Infus Chemotherapy 1993; 3: 111-118.
15. Hanson R H, Quebbeman E, Beatty P et al. Continuous 5-fluorouracil infusion in refractory carcinoma of the breast. Breast Cancer Res Treat 1987; 10: 145-149.
16. Lind M J, McGowan A T, Hadfield J A, Thatcher N, Crowther D, Fox B W. The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivo. Biochem Pharmacol 1989; 38: 1835-1840.
17. Hayward J L, Carbone P P, Heuson J C, Kumaoka S, Segaloff A, Rubens R D. Assessment of response to therapy in advanced breast cancer. Eur J Cancer 1977; 13: 89.